Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) investors of a class action representing investors that bought securities between November 2, 2023 and October 30, 2024, inclusive (the "Class Period"). Regeneron investors have until March 10, 2025 to file a lead plaintiff motion. Investors are encouraged to contact ...